Form 8-K

Send us Feedback

Medivation (MDVN)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Apr 1, 2013)8-K (Feb 28, 2013)8-K (Feb 4, 2013)8-K (Feb 1, 2013)8-K (Dec 20, 2012)8-K (Dec 12, 2012)8-K (Nov 9, 2012)8-K (Nov 1, 2012)8-K (Oct 25, 2012)8-K (Oct 22, 2012)8-K (Oct 2, 2012)8-K (Sep 24, 2012)8-K (Aug 31, 2012)8-K (Aug 28, 2012)8-K (Aug 9, 2012)8-K (Aug 3, 2012)8-K (Jul 24, 2012)8-K (Jul 18, 2012)8-K (Jun 27, 2012)8-K (Jun 6, 2012)8-K (Jun 4, 2012)8-K (May 22, 2012)8-K (May 8, 2012)8-K (Mar 19, 2012)8-K (Feb 29, 2012)8-K (Feb 3, 2012)8-K (Feb 1, 2012)8-K (Jan 20, 2012)8-K (Jan 17, 2012)8-K (Jan 9, 2012)8-K (Jan 6, 2012)8-K (Dec 15, 2011)8-K (Nov 9, 2011)8-K (Nov 3, 2011)8-K (Sep 27, 2011)8-K (Sep 8, 2011)8-K (Aug 9, 2011)8-K (Jul 8, 2011)8-K (May 6, 2011)8-K (Apr 11, 2011)8-K (Mar 16, 2011)8-K (Feb 16, 2011)8-K (Dec 7, 2010)8-K (Nov 29, 2010)8-K (Nov 5, 2010)8-K (Sep 29, 2010)8-K (Sep 10, 2010)8-K (Aug 9, 2010)8-K (Jun 17, 2010)8-K (May 10, 2010)8-K (Mar 29, 2010)8-K (Mar 15, 2010)8-K (Mar 10, 2010)8-K (Mar 3, 2010)8-K (Dec 17, 2009)8-K (Dec 7, 2009)8-K (Nov 6, 2009)8-K (Nov 4, 2009)8-K (Nov 3, 2009)8-K (Oct 27, 2009)8-K (Sep 23, 2009)8-K (Aug 5, 2009)8-K (Jul 31, 2009)8-K (Jun 11, 2009)8-K (Jun 2, 2009)8-K (May 28, 2009)8-K (May 27, 2009)8-K (May 11, 2009)8-K (Mar 18, 2009)8-K (Mar 16, 2009)8-K (Feb 25, 2009)8-K (Jan 20, 2009)8-K (Dec 17, 2008)8-K (Nov 10, 2008)8-K (Nov 5, 2008)8-K (Oct 28, 2008)8-K (Oct 22, 2008)8-K (Sep 3, 2008)8-K (Aug 11, 2008)8-K (Jul 30, 2008)8-K (Jul 18, 2008)8-K (Jul 7, 2008)8-K (Jun 23, 2008)8-K (May 5, 2008)8-K (May 1, 2008)8-K (Feb 19, 2008)8-K (Jan 28, 2008)8-K (Jan 15, 2008)8-K (Nov 13, 2007)8-K (Nov 5, 2007)8-K (Oct 26, 2007)8-K (Oct 9, 2007)8-K (Sep 10, 2007)8-K (Jul 30, 2007)8-K (Jul 25, 2007)8-K (Jul 2, 2007)8-K (Jun 11, 2007)8-K (May 8, 2007)8-K (May 3, 2007)8-K (Mar 23, 2007)8-K (Mar 8, 2007)8-K (Dec 8, 2006)8-K (Dec 4, 2006)8-K (Nov 15, 2006)8-K (Oct 27, 2006)8-K (Sep 28, 2006)8-K (Sep 21, 2006)8-K (Jul 17, 2006)8-K (May 19, 2006)8-K (May 11, 2006)8-K (Jan 20, 2006)8-K (Dec 27, 2005)8-K (Dec 19, 2005)8-K (Oct 11, 2005)8-K (May 25, 2005)8-K (May 20, 2005)8-K (May 13, 2005)8-K (May 2, 2005)8-K (Mar 4, 2005)8-K (Dec 20, 2004)8-K (Sep 17, 2004)8-K (Jun 28, 2004)8-K (Mar 11, 2004)8-K (Dec 12, 2003)8-K (Dec 8, 2000)8-K (Dec 4, 2000)8-K (Jun 21, 2000)8-K (May 3, 1999)8-K (Jul 12, 1996)

Other

Medivation 8-K 2012

Documents found in this filing:

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 31, 2012

MEDIVATION, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-32836

13-3863260

(State or other jurisdiction

of incorporation)

(Commission

File No.)

(IRS Employer

Identification No.)

201 Spear Street, 3^rd Floor

San Francisco, California 94105

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (415) 543-3470

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.

Other Events.

On January 31, 2012, Medivation, Inc. and Astellas Pharma Inc. issued a joint press release entitled “Medivation and Astellas Announce Positive Results from the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy.” A copy of the joint press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.

Item 9.01.

Financial Statements and Exhibits.

(d)

Exhibits.



99.1		Press release, dated January 31, 2012, entitled “Medivation and Astellas Announce Positive Results from the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy.”

-1-

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	MEDIVATION, INC.

Dated: February 1, 2012	By:	/s/ C. Patrick Machado
		C. Patrick Machado
		Chief Business Officer and Chief Financial Office

EXHIBIT INDEX



99.1		Press release, dated January 31, 2012, entitled “Medivation and Astellas Announce Positive Results from the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy.”

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Medivation (MDVN)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: